The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
C75, a Fatty Acid Synthase Inhibitor, Reduces Food Intake via Hypothalamic AMP-activated Protein Kinase
Open accessAbstract
Energy homeostasis and feeding are regulated by the central nervous system. C75, a fatty acid synthase (FAS) inhibitor, causes weight loss and anorexia, implying a novel central nervous system pathway(s) for sensing energy balance. AMP-activated protein kinase (AMPK), a sensor of peripheral energy balance, is phosphorylated and activated when energy sources are low. Here, we identify a role for hypothalamic AMPK in the regulation of feeding behavior and in mediating the anorexic effects of C75. 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR), an activator of AMPK, increased food intake, whereas compound C, an inhibitor of AMPK, decreased food intake. C75 rapidly reduced the level of the phosphorylated AMPK α subunit (pAMPKα) in the hypothalamus, even in fasted mice that had elevated hypothalamic pAMPKα levels. Furthermore, AICAR reversed both the C75-induced anorexia and the decrease in hypothalamic pAMPKα levels. C75 elevated hypothalamic neuronal ATP levels, which may contribute to the mechanism by which C75 decreased AMPK activity. C75 reduced the levels of pAMPKα and phosphorylated cAMP response element-binding protein (pCREB) in the arcuate nucleus neurons of the hypothalamus, suggesting a mechanism for the reduction in NPY expression seen with C75 treatment. These data indicate that modulation of FAS activity in the hypothalamus can alter energy perception via AMPK, which functions as a physiological energy sensor in the hypothalamus. Energy homeostasis and feeding are regulated by the central nervous system. C75, a fatty acid synthase (FAS) inhibitor, causes weight loss and anorexia, implying a novel central nervous system pathway(s) for sensing energy balance. AMP-activated protein kinase (AMPK), a sensor of peripheral energy balance, is phosphorylated and activated when energy sources are low. Here, we identify a role for hypothalamic AMPK in the regulation of feeding behavior and in mediating the anorexic effects of C75. 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR), an activator of AMPK, increased food intake, whereas compound C, an inhibitor of AMPK, decreased food intake. C75 rapidly reduced the level of the phosphorylated AMPK α subunit (pAMPKα) in the hypothalamus, even in fasted mice that had elevated hypothalamic pAMPKα levels. Furthermore, AICAR reversed both the C75-induced anorexia and the decrease in hypothalamic pAMPKα levels. C75 elevated hypothalamic neuronal ATP levels, which may contribute to the mechanism by which C75 decreased AMPK activity. C75 reduced the levels of pAMPKα and phosphorylated cAMP response element-binding protein (pCREB) in the arcuate nucleus neurons of the hypothalamus, suggesting a mechanism for the reduction in NPY expression seen with C75 treatment. These data indicate that modulation of FAS activity in the hypothalamus can alter energy perception via AMPK, which functions as a physiological energy sensor in the hypothalamus. Despite significant advances in the understanding of appetite and satiety at molecular levels (1Wilding J.P. Diabet. Med. 2002; 19: 619-627Crossref PubMed Scopus (145) Google Scholar, 2Schwartz M. Woods S. Porte D.J. Seeley R. Baskin D. Nature. 2000; 404: 661-671Crossref PubMed Scopus (4865) Google Scholar, 3Woods S.C. Schwartz M.W. Baskin D.G. Seeley R.J. Annu. Rev. Psychol. 2000; 51: 255-277Crossref PubMed Scopus (270) Google Scholar), practical therapies for weight loss remain elusive. We and others (4Loftus T. Jaworsky D. Frehywot G. Townsend C. Ronnett G. Lane M. Kuhajda F. Science. 2000; 288: 2379-2381Crossref PubMed Scopus (832) Google Scholar, 5Clegg D.J. Wortman M.D. Benoit S.C. McOsker C.C. Seeley R.J. Diabetes. 2002; 51: 3196-3201Crossref PubMed Scopus (80) Google Scholar, 6Kumar M.V. Shimokawa T. Nagy T.R. Lane M.D. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 1921-1925Crossref PubMed Scopus (112) Google Scholar, 7Shimokawa T. Kumar M.V. Lane M.D. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 66-71Crossref PubMed Scopus (171) Google Scholar, 8Thupari J.N. Landree L.E. Ronnett G.V. Kuhajda F.P. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 9498-9502Crossref PubMed Scopus (215) Google Scholar) have demonstrated that C75, a synthetic fatty acid synthase (FAS) 1The abbreviations used are: FAS, fatty acid synthase; CPT-1, carnitine palmitoyltransferase-1; AMPK, AMP-activated protein kinase; i.c.v., intracerebroventricular; i.p., intraperitoneal; FITC, fluorescein isothiocyanate; CREB, cAMP response element-binding protein; pCREB, phosphorylated CREB. 1The abbreviations used are: FAS, fatty acid synthase; CPT-1, carnitine palmitoyltransferase-1; AMPK, AMP-activated protein kinase; i.c.v., intracerebroventricular; i.p., intraperitoneal; FITC, fluorescein isothiocyanate; CREB, cAMP response element-binding protein; pCREB, phosphorylated CREB. inhibitor, caused profound weight loss and anorexia in lean, diet-induced obese (DIO) and genetically obese (ob/ob) mice. In addition to FAS inhibition, C75 also stimulates carni
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lee, M., Hwang, J.-T., Lee, H.-J., Jung, S.-N., Kang, I., Chi, S.-G., Kim, S.-S., & Ha, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306104200 · Cited by 235
RetractedCentral nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
THE AMP-ACTIVATED/SNF1 PROTEIN KINASE SUBFAMILY: Metabolic Sensors of the Eukaryotic Cell?
Hardie, D. G., Carling, D., & Carlson, M. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.821 · Cited by 1,435
The AMP‐Activated Protein Kinase: Fuel Gauge of the Mammalian Cell?
Hardie, D. G., & Carling, D. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00259.x · Cited by 1,317
Hawley, S. A., Davison, M., Woods, A., Davies, S. P., Beri, R. K., Carling, D., & Hardie, D. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27879 · Cited by 1,264
Corton, J. M., Gillespie, J. G., Hawley, S. A., & Hardie, D. G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0558k.x · Cited by 1,230
Elmquist, J. K., Elias, C. F., & Saper, C. B. (1999) · Neuron · doi:10.1016/s0896-6273(00)81084-3 · Cited by 1,160
Reduced Food Intake and Body Weight in Mice Treated with Fatty Acid Synthase Inhibitors
Loftus, T. M., Jaworsky, D. E., Frehywot, G. L., Townsend, C. A., Ronnett, G. V., Lane, M. D., & Kuhajda, F. P. (2000) · Science · doi:10.1126/science.288.5475.2379 · Cited by 1,004
Self-citationLeptin Differentially Regulates NPY and POMC Neurons Projecting to the Lateral Hypothalamic Area
Elias, C. F., Aschkenasi, C., Lee, C., Kelly, J., Ahima, R. S., Bjorbæk, C., Flier, J. S., Saper, C. B., & Elmquist, J. K. (1999) · Neuron · doi:10.1016/s0896-6273(01)80035-0 · Cited by 924
Mu, J., Brozinick, J. T., Valladares, O., Bucan, M., & Birnbaum, M. J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00251-9 · Cited by 924
Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2
Abu-Elheiga, L., Matzuk, M. M., Abo-Hashema, K. A. H., & Wakil, S. J. (2001) · Science · doi:10.1126/science.1056843 · Cited by 903
Marsin, A.-S., Bertrand†, L., Rider, M. H., Deprez, J., Beauloye, C., Vincent‡, M. F., Van den Berghe‡, G., Carling, D., & Hue, L. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00742-9 · Cited by 824
AMP‐activated protein kinase: the energy charge hypothesis revisited
Hardie, D. G., & Hawley, S. A. (2001) · BioEssays · doi:10.1002/bies.10009 · Cited by 784
AMP-activated Protein Kinase Plays a Role in the Control of Food Intake
Andersson, U., Filipsson, K., Abbott, C. R., Woods, A., Smith, K., Bloom, S. R., Carling, D., & Small, C. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300557200 · Cited by 755
5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle.
Kurth-Kraczek, E. J., Hirshman, M. F., Goodyear, L. J., & Winder, W. W. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1667 · Cited by 713
Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle
Winder, W. W., Holmes, B. F., Rubink, D. S., Jensen, E. B., Chen, M., & Holloszy, J. O. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.6.2219 · Cited by 709
Obici, S., Feng, Z., Arduini, A., Conti, R., & Rossetti, L. (2003) · Nature Medicine · doi:10.1038/nm873 · Cited by 548
Dealing with energy demand: the AMP-activated protein kinase
Kemp, B. E., Mitchelhill, K. I., Stapleton, D., Michell, B. J., Chen, Z.-P., & Witters, L. A. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01340-1 · Cited by 521
Sullivan, J. E., Brocklehurst, K. J., Marley, A. E., Carey, F., Carling, D., & Beri, R. K. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01006-4 · Cited by 485
SALT, I., CELLER, J. W., HAWLEY, S. A., PRESCOTT, A., WOODS, A., CARLING, D., & HARDIE, D. G. (1998) · Biochemical Journal · doi:10.1042/bj3340177 · Cited by 437
Role of the AMP-activated protein kinase in the cellular stress response
Corton, J. M., Gillespie, J. G., & Hardie, D. G. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00070-1 · Cited by 428
Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle
Winder, W. W. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.3.1017 · Cited by 375
Musi, N., Fujii, N., Hirshman, M. F., Ekberg, I., Fröberg, S., Ljungqvist, O., Thorell, A., & Goodyear, L. J. (2001) · Diabetes · doi:10.2337/diabetes.50.5.921 · Cited by 371
AMP-Activated Protein Kinase: An Ultrasensitive System for Monitoring Cellular Energy Charge
HARDIE, D. G., SALT, I. P., HAWLEY, S. A., & DAVIES, S. P. (1999) · Biochemical Journal · doi:10.1042/bj3380717 · Cited by 362
Culmsee, C., monnig, J., Kemp, B. E., & Mattson, M. P. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:1:45 · Cited by 340
Food Intake and the Regulation of Body Weight
Woods, S. C., Schwartz, M. W., Baskin, D. G., & Seeley, R. J. (2000) · Annual Review of Psychology · doi:10.1146/annurev.psych.51.1.255 · Cited by 333
Ponticos, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1688 · Cited by 317
Minireview: Malonyl CoA, AMP-Activated Protein Kinase, and Adiposity
Ruderman, N. B., Saha, A. K., & Kraegen, E. W. (2003) · Endocrinology · doi:10.1210/en.2003-0849 · Cited by 266
Turnley, A. M., Stapleton, D., Mann, R. J., Witters, L. A., Kemp, B. E., & Bartlett, P. F. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721707.x · Cited by 262
C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity
Thupari, J. N., Landree, L. E., Ronnett, G. V., & Kuhajda, F. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132128899 · Cited by 262
Self-citationRole of AMP-activated protein kinase in the regulation by glucose of islet beta cell gene expression
da Silva Xavier, G., Leclerc, I., Salt, I. P., Doiron, B., Hardie, D. G., Kahn, A., & Rutter, G. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4023 · Cited by 203
Neuropeptides and appetite control
Wilding, J. P. H. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00790.x · Cited by 189
Shimokawa, T., Kumar, M. V., & Lane, M. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012606199 · Cited by 186
Regulation of fatty acid and cholesterol metabolism by the AMP-activated protein kinase
Hardie, D. G. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90001-c · Cited by 183
AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins
Leff, T. (2003) · Biochemical Society Transactions · doi:10.1042/bst0310224 · Cited by 161
Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice
Kumar, M. V., Shimokawa, T., Nagy, T. R., & Lane, M. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042683699 · Cited by 152
5-Amino-4-imidazolecarboxamide riboside (Z-riboside) metabolism in eukaryotic cells.
Sabina, R. L., Patterson, D., & Holmes, E. W. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)88943-8 · Cited by 148
Landree, L. E., Hanlon, A. L., Strong, D. W., Rumbaugh, G., Miller, I. M., Thupari, J. N., Connolly, E. C., Huganir, R. L., Richardson, C. A., Witters, L. A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310991200 · Cited by 143
Self-citationDavies, J., & Riechmann, L. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01313-x · Cited by 131
Clegg, D. J., Wortman, M. D., Benoit, S. C., McOsker, C. C., & Seeley, R. J. (2002) · Diabetes · doi:10.2337/diabetes.51.11.3196 · Cited by 94
Fraley, M. E., Rubino, R. S., Hoffman, W. F., Hambaugh, S. R., Arrington, K. L., Hungate, R. W., Bilodeau, M. T., Tebben, A. J., Rutledge, R. Z., Kendall, R. L., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00827-2 · Cited by 88
Witters, L. A., Gao, G., Kemp, B. E., & Quistorff, B. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1058 · Cited by 87
Shimizu‐Albergine, M., Ippolito, D. L., & Beavo, J. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01238.2001 · Cited by 78
C75 inhibits food intake by increasing CNS glucose metabolism
Wortman, M. D., Clegg, D. J., D’Alessio, D. A., Woods, S. C., & Seeley, R. J. (2003) · Nature Medicine · doi:10.1038/nm0503-483 · Cited by 71
Identification of Raf‐1 Ser621 kinase activity from NIH 3T3 cells as AMP‐activated protein kinase
Sprenkle, A. B., Davies, S. P., Carling, D., Hardie, D. G., & Sturgill, T. W. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00062-8 · Cited by 59
AMP-Activated Protein Kinase: Possible Target for Treatment of Type 2 Diabetes
Winder, W. W. (2000) · Diabetes Technology & Therapeutics · doi:10.1089/15209150050194305 · Cited by 58
Sheriff, S., Chance, W. T., Fischer, J. E., & Balasubramaniam, A. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.4.597 · Cited by 57
Cited by
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Steinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637
Woods, A., Dickerson, K., Heath, R., Hong, S.-P., Momcilovic, M., Johnstone, S. R., Carlson, M., & Carling, D. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.06.005 · Cited by 1,392
Metadata
- Authors
- Kim, E.-K., Miller, I., Aja, S., Landree, L. E., Pinn, M., McFadden, J., Kuhajda, F. P., Moran, T. H., & Ronnett, G. V.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-05
- Volume
- 279
- Issue
- 19
- Pages
- 19970-19976
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2035703541
- Cited by
- 303
- References
- 51
- FWCI
- 9.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.